The application of atomic absorption spectrometry for the determination of residual active pharmaceutical ingredients in cleaning validation samples

Abstract

The objective of this work was the development and validation of atomic absorption spectrometric (AAS) methods for the determination of residual active pharmaceutical ingredients (API) in rinse samples for cleaning validation. AAS as an indirect method for the determination of API in rinse samples can be applied when it is in the form of salt with metal ions or when the metal ion is a part of the API's structure. The electrothermal AAS methods (aqueous and ethanol medium) for the determination of magnesium in esomeprazole magnesium and the flame AAS method for the determination of lithium in lithium carbonate in rinse samples were developed. Various combinations of solvents were tested and a combination of 1% aqueous or ethanol solution of nitric acid for esomeprazole magnesium and 0.1% aqueous solution of nitric acid for lithium carbonate were found to be the most suitable. The atomization conditions in the graphite furnace and in the flame were carefully studied to avoid losses of analyte and to achieve suitable sensitivity. The cleaning verification methods were validated with respect to accuracy, precision, linearity, limit of detection, and quantification. In all the cases, the limits of detection were at the microgram level. The methods were successfully applied for the determination of esomeprazole magnesium and lithium carbonate in rinse samples from cleaning procedures.

• Electrothermal atomic absorption spectrometry
• esomeprazole magnesium
• flame atomic absorption spectrometry
• lithium carbonate
• recovery
• validation

Acknowledgment

The research described in this article was carried out at the Quality Control, Lek Pharmaceuticals d.d., which is gratefully acknowledged.

Declaration of interest

The authors report no conflict of interest. The authors alone are responsible for the content and writing of this paper.